For patients with ocular symptoms of cystinosis, early intervention, monitoring and management is critical.
Cystinosis Overview
Ocular symptoms of cystinosis may manifest in infancy, and may lead to irreversible damage over time. As part of an integrated treatment plan, continuous symptom monitoring and management are vital in helping prevent vision complications as patients mature.
The following information provides details on this rare disease, as well as clinical approaches to managing the ocular symptoms of cystinosis.
Cystinosis affects multiple organs and systems, with cystine continuously accumulating in lysosomes, eventually forming crystals in cells throughout the body of affected patients.1 Generally diagnosed early in life, patients typically present with severe kidney manifestations.1,2 The kidneys and eyes are the most affected organs.1
Ocular Symptoms
Cystinosis is caused by mutations in the CTNS gene that encodes for a cystine transporter3,4:
Identifying Cystinosis
Over time, cystine crystals accumulate in cells throughout the body, eventually leading to symptoms in multiple organs:1,6,7
Cystinosis patients require a multidisciplinary approach to treatment. Bringing together a number of specialists to address and treat symptoms is essential for:
REFERENCES: 1. Cystinosis. National Organization for Rare Disorders. https://rarediseases.org/rare-diseases/cystinosis/?filter=ovr-ds-resources. Updated August 1, 2022. Accessed February 8, 2023. 2. Elmonem MA et al. Orphanet J Rare Dis. 2016;11:47. doi:10.1186/s13023-016-0426-y. 3. Wilmer MJ et al. Pediatr Nephrol. 2011;26(2):205-215. 4. Besouw MTP, Levtchenko EN. Improving the prognosis of nephropathic cystinosis. Int J Nephrol Renovasc Dis. 2014;7:297-302. 5. Nesterova N, Gahl WA. Pediatr Nephrol. 2013;28(1):51-59. 6. Gahl WA et al. N Engl J Med. 2002;347(2):111-121. 7. Bäumner S, Weber LT. Front Pediatr. 2018;6:58. doi:10.3389/fped.2018.00058. 8. Liang H et al. Br J Ophthalmol. 2021;105(5):608-613. 9. Tsilou E et al. Surv Ophthalmol. 2007;52(1):97-105. 10. Bayram-Suverza M et al. Indian J Ophthalmol. 2022;70(7):2636-2638.
You will be leaving our website and entering a website hosted by another party.
You are about to leave the CystinosisInFocus.com website. By clicking this link, you will be directed to a website owned by Recordati Rare Diseases to learn more about a medication option for appropriate patients that treats corneal cystine crystals in cystinosis.
Click CONTINUE to proceed or CANCEL to stay on CystinosisInFocus.com.
The information contained in this section of the website is intended for US healthcare professionals only. Click OK to confirm that you are a healthcare professional.
The Cystinosis Eye Care Specialist Directory aims to connect patients with healthcare professionals knowledgeable about ocular care in cystinosis.
Recordati Rare Diseases created this physician directory to help patients and caregivers find a healthcare professional that fits their needs. Patients can access the directory through cystinosisinfocus.com.
If you are a healthcare professional experienced in treatment and management of ocular manifestations of cystinosis and would like to be a part of the Cystinosis Eye Care Specialist Directory, please complete this enrollment form. HCPs will be listed in the directory for a maximum of two years, with the ability to opt-out at any time. If you have questions, please contact us at locator@cystinosisinfocus.com.
Asterisk (*) indicates a required field.
"*" indicates required fields